1. Home
  2. LOBO vs COCP Comparison

LOBO vs COCP Comparison

Compare LOBO & COCP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • LOBO
  • COCP
  • Stock Information
  • Founded
  • LOBO 2014
  • COCP N/A
  • Country
  • LOBO China
  • COCP United States
  • Employees
  • LOBO N/A
  • COCP N/A
  • Industry
  • LOBO
  • COCP Biotechnology: Pharmaceutical Preparations
  • Sector
  • LOBO
  • COCP Health Care
  • Exchange
  • LOBO NYSE
  • COCP Nasdaq
  • Market Cap
  • LOBO 13.6M
  • COCP 15.3M
  • IPO Year
  • LOBO 2024
  • COCP N/A
  • Fundamental
  • Price
  • LOBO $0.97
  • COCP $1.43
  • Analyst Decision
  • LOBO
  • COCP Strong Buy
  • Analyst Count
  • LOBO 0
  • COCP 1
  • Target Price
  • LOBO N/A
  • COCP $7.00
  • AVG Volume (30 Days)
  • LOBO 19.7K
  • COCP 17.0K
  • Earning Date
  • LOBO 04-08-2025
  • COCP 03-31-2025
  • Dividend Yield
  • LOBO N/A
  • COCP N/A
  • EPS Growth
  • LOBO N/A
  • COCP N/A
  • EPS
  • LOBO 0.00
  • COCP N/A
  • Revenue
  • LOBO $19,469,766.00
  • COCP N/A
  • Revenue This Year
  • LOBO $72.16
  • COCP N/A
  • Revenue Next Year
  • LOBO $41.04
  • COCP N/A
  • P/E Ratio
  • LOBO $908.63
  • COCP N/A
  • Revenue Growth
  • LOBO N/A
  • COCP N/A
  • 52 Week Low
  • LOBO $0.80
  • COCP $1.35
  • 52 Week High
  • LOBO $4.70
  • COCP $3.26
  • Technical
  • Relative Strength Index (RSI)
  • LOBO N/A
  • COCP 34.72
  • Support Level
  • LOBO N/A
  • COCP $1.38
  • Resistance Level
  • LOBO N/A
  • COCP $1.49
  • Average True Range (ATR)
  • LOBO 0.00
  • COCP 0.10
  • MACD
  • LOBO 0.00
  • COCP -0.00
  • Stochastic Oscillator
  • LOBO 0.00
  • COCP 12.82

About LOBO LOBO EV TECHNOLOGIES LTD

Lobo EV Technologies Ltd is an electric vehicle manufacturer and seller company. It designs, develops, manufactures, and sells e-bicycles, e-mopeds, e-tricycles, and electric off-highway four-wheeled shuttles such as golf carts and mobility scooters for the elderly and disabled persons, also provides automobile information and entertainment software development and design services to customers. The company operates in two operating segments: Electric vehicles and accessories sales which generates key revenue, and software royalties and development and design services. It generates all of its revenue within the People's Republic of China.

About COCP Cocrystal Pharma Inc.

Cocrystal Pharma Inc is a biotechnology company discovering and developing novel antiviral therapeutics that target the replication machinery of influenza viruses, hepatitis C viruses, and noroviruses. It employs structure-based technologies and Nobel Prize-winning expertise to create first- and-in-class antiviral drugs. It is developing CC-31244, an investigational, oral, broad-spectrum replication inhibitor called a non-nucleoside inhibitor (NNI).

Share on Social Networks: